Liver Cancer in India: Risk Factors, Early Detection & Cure Options
By Dr. Chetan Kalal — Maharashtra’s First DM in Hepatology & International Liver Transplant Specialist
Introduction
Liver cancer — most commonly hepatocellular carcinoma (HCC) — is one of the fastest-rising cancers in India. Once considered rare, it is now appearing more frequently due to the surge in fatty liver disease, alcohol-related liver damage, and viral hepatitis.
The challenge is that liver cancer often develops silently in people who already have chronic liver disease or cirrhosis. By the time symptoms appear, it may be too late for curative treatment. The solution lies in early detection and timely referral to specialised liver centres.
Major Risk Factors for Liver Cancer in India
Chronic Hepatitis B & C infections
Cirrhosis from any cause (alcohol, viral, fatty liver)
Non-Alcoholic Fatty Liver Disease (NAFLD / MASLD) — now the fastest-growing cause of HCC
Aflatoxin exposure (contaminated grains/nuts, though less common now)
Family history of liver disease
Why Early Detection Matters
For high-risk patients (those with cirrhosis, hepatitis B carriers, or advanced fatty liver):
Ultrasound screening every 6 months is recommended.
A simple blood test (AFP – alpha-fetoprotein) may also help detect early disease.
Catching HCC early can make the difference between curative treatment (surgery, ablation, transplant) and palliative care.
Latest Treatments for Liver Cancer
Treatment depends on the stage of the cancer and the health of the liver:
Curative options:
Surgical resection (removal of part of the liver): Best for patients with good liver function and no major portal hypertension.
Liver transplantation: Ideal for patients with cirrhosis and cancer within transplant criteria (Milan/UCSF criteria). Offers cure for both the tumour and the underlying liver disease.
Local ablation (RFA, microwave): Minimally invasive, used for small tumours.
Advanced disease options:
TACE (Transarterial Chemoembolisation) and TARE (radioembolisation): Block blood supply to the tumour.
Systemic therapy: New targeted drugs (sorafenib, lenvatinib) and immunotherapy (nivolumab, atezolizumab-bevacizumab) are improving survival.
FAQs
Q1. Can fatty liver progress to liver cancer?
Yes. Advanced fatty liver (with cirrhosis) is now one of the leading causes of liver cancer worldwide, including India. Even without cirrhosis, some patients with fatty liver can develop HCC, which is why early monitoring is important.
Q2. What are the latest treatments for liver cancer?
Treatment ranges from surgery, liver transplantation, and ablation in early stages, to TACE, TARE, targeted therapies, and immunotherapy in advanced cases. Choice depends on tumour size, spread, and liver function.
Q3. Is transplant better than surgery for liver cancer?
For patients with cirrhosis and liver cancer within transplant criteria, transplant offers the best chance of long-term cure, as it removes both the tumour and the diseased liver. For patients with healthy liver function, surgery may be equally effective.
Closing Note
Liver cancer is not just a diagnosis — it is a warning sign that chronic liver disease has reached a dangerous stage. But with regular screening, early detection, and modern therapies, cure is possible.
As Maharashtra’s First DM Hepatologist and one of India’s top liver transplant specialists, I urge high-risk individuals — those with hepatitis B/C, cirrhosis, or fatty liver — to undergo regular monitoring. Timely action saves lives.
Title: Liver Cancer in India: Risk Factors, Early Detection & Cure Options | Dr. Chetan Kalal
Liver cancer is rising in India due to fatty liver, hepatitis, and cirrhosis. Dr. Chetan Kalal, leading hepatologist & transplant specialist, explains causes, early detection, and cure options.
